[June 16, 2017] |
|
ICON and DIA Amplify Thought Leadership and Debate with DIA Live 2017
ICON plc, (NASDAQ: ICLR) a global provider of drug development
solutions and services to the pharmaceutical, biotechnology and medical
device industries, today announced that for the second consecutive year
it will present DIA
Live - a social media aggregation site that allows visitors to track
and analyse Twitter (News - Alert) conversations from delegates at the DIA
2017 Annual Meeting (18 - 22 June, Chicago, IL).
DIA is the largest global interdisciplinary gathering of life sciences
professionals, with over 7,000 visitors from over 50 countries. DIA Live
will provide a single source for visitors to view the social media
conversations from conference participants, alongside broader
conversations from Twitter users around the world using the hashtag
#DIA2017. DIA Live will launch on the 17June and will aggregate and
stream a live feed of tweets sent by conference delegates as well as
other industry participants.
DIA Live features include:
-
Real-time view of trending topics, breaking news stories and expert
commentary from the conference
-
Filtering, by keyword, hashtag, content format or Twitter profile to
enable easy personalisation of content
-
Ability for visitors to create and publish stories and to engage with
the most influential experts in the industry
-
For bloggers and media publications, the ability to create and
customise widgets that can be easily embedded in other websites,
providing a real-time stream of content and infographics from DIA Live
-
An interactive timeline that presents activity volumes, key highlights
and the ability to review conversations from prior days as the
conference progresses
This is the second time that ICON and DIA have collaborated to present
DIA Live. In 2016 the platform analysed over 4.5K tweets from conference
delegates discussing a variety of industry topics, ranging from big data
and cyber security to patient engagement and health care regulation.
David Green, VP Marketing, ICON said "Following the success of DIA Live
2016, we are delighted to continue our collaboration with DIA to help
industry professionals join the conversation on a variety of important
topics, including disruptive innovation, special patient populations,
translational science and value and market access. DIA Live combines
powerful data analysis and visualisation features to provide a unique
digital forum to connect the world's largest gathering of life sciences
professionals."
"DIA Live will provide valuable insight and analysis into the
conversations taking place at DIA 2017 Global Annual Meeting while
enabling individuals from around the world to engage and participate in
the discussions covering the most pressing issues faing the life
sciences industry today," said Sudip Parikh SVP and Managing Director,
DIA Americas. "This DIA Live social media aggregation site offers a
digital window into the world's largest gathering of life science
industry professionals highlighting digital conversation hotspots and
helping to amplify thought leadership and debate at DIA 2017. If you're
onsite at this year's event it will add to your experience and if you're
not, it's the second best thing."
To join the 2017 DIA conversation, follow and engage with our team via www.dialive.org
About DIA 2017
DIA
2017 is DIA's global annual meeting to advance health care product
development around the world by connecting stakeholders to
interdisciplinary insights and innovation. As the organization's largest
interdisciplinary event, DIA 2017 is a gathering of global perspectives
bringing together a network of more than 7,000 professionals to foster
innovation that leads to the development of safe and effective products
and therapies to patients. The global annual meeting will draw attendees
from 51 countries for the five-day conference, which also features a
three-day expo with more than 450 exhibitors. For more information visit http://www.diaglobal.org/Flagship/DIA-2017
or follow DIA on Twitter,
LinkedIn,
and Facebook. Join
the conversation using #DIA2017
About ICON plc
ICON plc is a global provider of drug development solutions and services
to the pharmaceutical, biotechnology and medical device industries. The
company specialises in the strategic development, management and
analysis of programs that support clinical development - from compound
selection to Phase I-IV clinical studies. With headquarters in Dublin,
Ireland, ICON currently, operates from 87 locations in 38 countries and
has approximately 12,300 employees.
Further information is available at www.iconplc.com
ICON/ICLR-G
This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and industry
conditions. These statements are not guarantees of future performance or
actual results, and actual results, developments and business decisions
may differ from those stated in this press release. The forward-looking
statements are subject to future events, risks, uncertainties and other
factors that could cause actual results to differ materially from those
projected in the statements, including, but not limited to, the ability
to enter into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the integration of
new business mergers and acquisitions, as well as economic and global
market conditions and other risks and uncertainties detailed from time
to time in SEC (News - Alert) reports filed by ICON, all of which are difficult to
predict and some of which are beyond our control. For these reasons, you
should not place undue reliance on these forward-looking statements when
making investment decisions. The word "expected" and variations of such
words and similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they are
made and we do not undertake any obligation to update publicly any
forward-looking statement, either as a result of new information, future
events or otherwise. More information about the risks and uncertainties
relating to these forward-looking statements may be found in SEC reports
filed by ICON, including its Form 20-F, F-1, S-8 and F-3, which are
available on the SEC's website at http://www.sec.gov.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170616005181/en/
[ Back To Homepage ]
|